UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Stringent social distancing can calm Covid-19 in early September’
The nation’s daily new cases of Covid-19 rebounded to exceed 300 on Wednesd...
by Song Soo-youn
|
2020-08-26 16:25
라인
Why medical school students give up pursuing public health jobs
A total of 2,811 seniors of the six-year medical colleges and the four-year...
by Song Soo-youn
|
2020-08-26 16:21
라인
HK inno.N, T&R Biofab to develop skin therapy using 3D tech
HK inno.N has teamed up with T&R Biofab to test the efficacy of its skin di...
by Shim Hyun-tai
|
2020-08-26 16:19
라인
Virus cases rebound above 300, pushing nation closer to tightest restrictions
Korea’s new Covid-19 cases climbed back above 300 Wednesday, stepping up pr...
by Shim Hyun-tai
|
2020-08-26 13:35
라인
Novartis fails trial on skin cancer drug candidate spartalizumab
Novartis said it its phase-3 trial on immunotherapy spartalizumab, a progra...
by Kim Yun-mi
|
2020-08-26 11:11
라인
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status
CrystalGenomics said Monday that the U.S. Food and Drug Administration has ...
by Shim Hyun-tai
|
2020-08-25 17:07
라인
[Column] How ongoing doctors’ strike is different from 20 years ago
The recent series of strikes by physicians are different from those two dec...
by Park Jae-young Executive editor
|
2020-08-25 17:07
라인
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate
PharmAbcine, a bio company specializing in antibody therapies, said Tuesday...
by Shim Hyun-tai
|
2020-08-25 16:57
라인
Huons' eye drop wins Saudi’s regulatory nod
Huons' flagship eye drop product entered the Saudi Arabia market, signa...
by Shim Hyun-tai
|
2020-08-25 14:50
라인
New virus cases below 300 for 2nd day but spreads continue
Korea saw new Covid-19 cases of below 300 for the second day on Tuesday but...
by Shim Hyun-tai
|
2020-08-25 11:51
라인
Drugmakers in active open innovation with startups
The local pharmaceutical industry is increasingly seeking “open innovation,...
by Kim Chan-hyuk
|
2020-08-25 11:51
라인
HK inno.N publishes P3 trial results of drug on gastric ulcers
HK inno.N has published the results of phase 3 clinical trial of gastroesop...
by Shim Hyun-tai
|
2020-08-24 18:02
라인
Intron Bio secures new drug substance for bacterial pneumonia
Intron Biotechnology said Monday that it has secured a new drug substance, ...
by Shim Hyun-tai
|
2020-08-24 18:01
라인
GC Pharma collects more plasma to speed up work on Covid-19 treatment
GC Pharma said it would collect more plasma from recovered Covid-19 patient...
by Kim Chan-hyuk
|
2020-08-24 17:15
라인
Regulator OKs Pfizer’s cardiomyopathy drug Vyndamax
The Ministry of Food and Drug Safety has approved Pfizer's Vyndamax (in...
by Shim Hyun-tai
|
2020-08-24 16:12
라인
Genexine begins global P3 trial of anemia drug
Genexine said Monday that the company has begun administering its long-acti...
by Shim Hyun-tai
|
2020-08-24 16:12
라인
Despite fall in new virus cases, calls rise for tightest social distancing
New virus cases dropped below 300 on Monday, but epidemiological experts ca...
by Shim Hyun-tai
|
2020-08-24 15:42
라인
Korea’s healthcare exports expand 36% in July
The nation’s exports of healthcare products rose 36 percent in July from a ...
by Kwak Sung-sun
|
2020-08-24 14:54
라인
‘Daily confirmed cases could hit 2,800 in 2 weeks if left uncontrolled’
The health authorities must implement the toughest social distancing to con...
by Song Soo-youn
|
2020-08-24 11:39
라인
Korea at crossroads of nationwide epidemic, expands tighter restrictions to whole country
Korea’s new virus cases exceeded 300 for two consecutive days on Saturday, ...
by Shim Hyun-tai
|
2020-08-22 19:08
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top